Intrinsic Value
Cyclerion Therapeutics, Inc. (CYCN)
$3.04
+0.13 (+4.47%)
Enterprise Value | -27.66 |
---|---|
Net Debt | -7.57 |
Equity Value | -20.09 |
Shares Outstanding | 2.34 |
Equity Value Per Share | -8.59 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt